Animal Vaccines Market

Animal Vaccines Market Overview

The global Animal Vaccines Market size was valued at USD 10.23 billion in 2021 and is expected to reach USD 18.96 billion by 2030, with a CAGR of 7.1% from 2022 to 2030. Animal vaccine is a kind of booster dose for providing immunity to the domestic & wild animals.

Vaccines are the most cost-effective measures in preventing disease in livestock populations. It is formulated to build extra power in the immune system to fight future infections and disease-causing agents. It plays an important role in animal healthcare through prevention of various communicable diseases such as anthrax, black quarter (black-leg), and rabies (mad dog disease).

Market Dynamics and Trends

Growing dependency of humans on animal for food production, rising pet adoption, and the need to increase antibiotic resistance among animals with growing bacteria content in their intestines are expected to drive the growth of the global animal vaccines market.

Moreover, the growing demand for animal vaccines has led to the development of multiple new vaccines among various companies. For instance, Cevac IBron, a new vaccine launched by Ceva, prevents infectious bronchitis virus (IBV). These factors are expected to further propel the growth of animal vaccines market in forecasted period.

However, possibility of adverse impact of veterinary vaccines on animal health, lack of animal health awareness among uneducated people, and high cost of vaccines are the factors that restrain the growth of the market. On the contrary, surge in investments in R&D activities of vaccines that inhibit the growth of antibiotic-resistant organisms are expected to create ample opportunities for the market in the coming years.

Market Segmentations and Scope of the Study

The global animal vaccines market share is segmented on the basis of product, animal type, route of administration, and geography. On the basis of product, the market is categorized into DNA vaccines, inactivated vaccines, toxoid vaccines, subunit vaccines, attenuated vaccines, conjugate vaccines, and recombinant vaccines. On the basis of animal type, the market is divided into livestock animal and companion animal.

On the basis of livestock animal, the market is sub segmented into fish, cattle, pigs, and sheep. On the basis of companion animal, the market is sub-classified into dog and cat. On the basis of route of administration, the market is divided into oral, immersion/spray, injection, and others. Geographic breakdown and analysis of each of the aforesaid segments includes regions such as North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America holds the major share of the animal vaccines market at present and is expected to continue its dominance during the forecast period. This is attributed to factors such as increase in adoption of pet animals and rise in zoonotic diseases such as plague, rabies, and brucellosis that can negatively impact human lives. The number of organizations such as North Shore Animal League America, The American Humane Society and The Humane Society of the United States (HSUS) are focused on the safety and well-being of animals.

Moreover, the introduction of third generation vaccine that includes DNA, RNA, and recombinant viral-vector vaccines is helpful in prevention of infections in animals. The companies that are involved in the production of these vaccines are Neogen Corporation and Dechra Pharmaceuticals. All the above-mentioned factors are expected to propel the market growth in this region.

Moreover, Asia-pacific is expected to show a steady rise in the market due to rising awareness of food security as people are dependent on animals for poultry farming in this region and rising canine disorder such as rabies, distemper, and hepatitis which leads to the demand of vaccines as it will lower the risk of infection in the bodies of animal.

Also, environmental degradation leading to imbalanced biodiversity along with growing pollution and climate change adversely affect the animal health. These factors can cause immune suppression, oxidative stress, and metabolic disruptions in animals. They may also lead to infections and death among animals. These factors increase the demand for animal vaccines, and are expected to drive the animal vaccines market growth in this region.

Competitive Landscape:

Key market players of the global animal vaccines market include Ceva Sante Animale, Boehringer Ingelheim Animal Health, Durvet, Inc., Dechra Pharmaceuticals., Henry Schein Animal Health, Elanco, Merck Animal Health, Hipra Animal Health Limited, Zoetis, and Neogen Corporation. These market players are adopting various strategies such as acquisitions and new product launches to maintain their dominance in the global animal vaccine market.

For instance, in May 2022, Ceva announced its strategic acquisition of Artemis Technologies, Inc. to complement its production and management of oral rabies vaccination campaigns in Europe and elsewhere, along with the expansion of its product portfolio and its presence in North America.  Also, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD).

Moreover, in January 2020, Merck Animal Health signed an agreement with Automazioni VX, Inc. (the U.S.). The partnership was aimed at introduction of Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized in combination with Merck Animal Health’s Innovax range of vaccines that are used for protection against infectious diseases in poultry.

Key Benefits

• The animal vaccines market report provides the quantitative analysis of the current market and estimations from 2022 to 2030. This analysis assists in identifying the prevailing market opportunities to capitalize on.

• The study comprises of a comprehensive analysis of the animal vaccines market trends including the current and future trends for depicting the prevalent investment pockets in the market.

• The information related to key drivers, restraints and opportunities and their impact on the animal vaccines market is provided in the report.

• The competitive analysis of the market players along with their market share in the animal vaccines market is mentioned.

• The SWOT analysis and Porter’s Five Forces model are elaborated in the study.

• The value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

Animal Vaccines Market Key Segments

By Product

• DNA Vaccines

• Inactivated Vaccines

• Toxoid Vaccines

• Subunit Vaccines

• Attenuated Vaccines

• Conjugate Vaccines

• Recombinant Vaccines

By Animal Type

• Livestock Animal

  • Fish

  • Cattle

  • Pigs

  • Sheep

• Companion Animal

  • Dog

  • Cat

By Route of Administration

• Oral

• Immersion/Spray

• Injection

• Others

By Geography

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Rest of Europe

• Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Rest of Asia-Pacific

• RoW

  • UAE

  • Saudi Arabia

  • South Africa

  • Brazil

  • Remaining countries

Key Players

• Ceva Sante Animale,

• Boehringer Ingelheim Animal Health

• Durvet, Inc

• Dechra Pharmaceuticals

• Henry Schein Animal Health

• Elanco

• Merck Animal Health

• Hipra Animal Health Limited

• Zoetis

• Neogen Corporation

REPORT SCOPE AND SEGMENTATION:

Parameters	Details
Analysis Period	2021–2030
Base Year Considered	2021
Forecast Period	2022–2030
Market Size Estimation	Billion (USD)
Market Segmentation	By Product (DNA Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Attenuated Vaccines, Conjugate Vaccines, and Recombinant Vaccines), by Animal Type (Livestock Animal and Companion Animal), and by Route of Administration (Oral, Immersion/Spray, Injection, and Others)
Geographical Segmentation	North America (U.S., Canada, Mexico) Europe (U.K., Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of Asia-Pacific), Rest of the World (UAE, Saudi Arabia, South Africa, Brazil, Remaining countries)
Companies Profiled	Ceva Sante Animale, Boehringer Ingelheim Animal Health, Durvet, Inc., Dechra Pharmaceuticals., Henry Schein Animal Health, Elanco, Merck Animal Health, Hipra Animal Health Limited, Zoetis, and Neogen Corporation.